grant

Establishing the clinical spectrum and pathogenicity of antibodies against dopamine receptors in autoimmune movement and psychiatric disorders [ 2013 - 2017 ]

Also known as: The clinical, radiological, and immunological characterisation of myelin oligodendrocyte glycoprotein antibodies in central nervous system demyelination.

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/1055322]

Researchers: Dr Sudarshini Ramanathan (Principal investigator)

Brief description Dopamine plays a pivotal role in neurotransmission and the control of movement and behaviour. This project aims to define the clinical spectrum and pathogenicity of anti-dopamine receptor antibody mediated diseases. The identification of these antibodies in atypical presentations of common movement disorders would have widespread diagnostic and therapeutic implications, and suggests that selected patients might be amenable to targeted immunomodulatory therapy, thus improving their outcome.

Funding Amount $AUD 172,126.06

Funding Scheme Postgraduate Scholarships

Notes Medical/Dental Postgraduate Scholarship

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]